Press Room

Find out the latest news from the Alliance and the field of aging research. Media members can call 202.370.7852 or email for more information and to schedule interviews. Download our online press kit here.

Alliance for Aging Research Vice President of Public Policy Cynthia Bens issued the following statement regarding congressional action taken this week to begin consideration of the U.S. Food and Drug Administration’s (FDA) prescription drug and medical device user fee programs.

The Alliance has joined with more than 90 national organizations in urging the Senate to ensure Secretary of HHS nominee Tom Price, M.D., is committed to protecting U.S. citizens from vaccine preventable diseases.

AIM Coalition Meeting Spotlights Sarcopenia Research Advances

Author: Noel Lloyd

Date: December 2nd, 2016

The Aging in Motion (AIM) Coalition hosted its second annual meeting with U.S. Food and Drug Administration (FDA) leaders and leading scientists, industry representatives, and advocates to discuss developments and advances in clinical research and treatment of sarcopenia in Bethesda, Md.

Today, senior representatives from the U.S. Food and Drug Administration (FDA) and the National Institute on Aging at the National Institutes of Health (NIH) joined with advocates, federal colleagues, researchers, and industry to explore collaborations for advancing the most up-to-date knowledge in Alzheimer’s disease research. 

Cynthia Bens has been named as the president of the Alliance for a Stronger FDA Board of Directors.

ACT-AD Coalition Hosts Its Eighth Annual Meeting

Results Also Reveal Many Older Adults Use OTC Medications to Relieve Pain

ACT-AD Coalition Hosts Its 7th Annual Meeting

Accelerate Cure/Treatments for Alzheimer’s Disease (ACT-AD) coalition released a statement in response to guidance from the U.S. Food and Drug Administration (FDA) on the development of drugs for Alzheimer’s Disease.

Use biomarkers in Alzheimer's disease clinical trials, says expert group.

Advocates: FDA deal with drug makers "opaque"

Author: J. Lester Feder, Politico Pro

Date: June 8th, 2011

Consumer advocates are blasting the FDA for the process it has used to renegotiate the terms of the drug approval process following news that a deal has been reached with industry on proposed changes to the process.

The Alliance for Aging Research today commends the Senate Agriculture, Rural Development, FDA and Related Agencies Appropriations Subcommittee for including a $186 million increase for the U.S. Food and Drug Administration (FDA) in its Fiscal Year 2008 appropriations bill.

The Alliance for Aging Research today warned that the president’s proposed FY 2008 budget lacks sufficient funding to address the growing burden of age-related chronic diseases.